جست‌وجوی استاد و پژوهشگر

Shannon L Macauleyمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Brain Metabolism
• Sleep Impairment
• +۶ مورد دیگر

Dr. Shannon L Macauley is an Associate Professor at the University of Kentucky's Sanders-Brown Center on Aging, Department of Physiology. Her research focuses on understanding how brain metabolism alterations relate to Alzheimer's disease pathophysiology, sleep impairment, and vascular dysfunction. She employs rodent models, non-human primates, and human data to explore metabolic interventions targeting neurodegenerative diseases. Dr. Macauley completed her BA in Biology/Psychology at Middlebury College, PhD in Neuroscience at Washington University School of Medicine, and postdoctoral training in Internal Medicine and Neurology at Washington University. She leads the Macauley Lab, which investigates pharmacological/non-pharmacological therapies for Alzheimer's and lysosomal storage disorders. Key recent work includes studies on KATP channels' role in amyloid-β pathology, sleep disruption's impact on CSF amyloid, and ethanol's effects on Alzheimer's-related biomarkers in mice. Affiliations: Sanders-Brown Center on Aging, University of Kentucky Research Interests: Metabolism-Alzheimer's interplay, neurovascular coupling, sleep-wake biology Lab Focus: Translational rodent/non-primate models, microglial immunometabolism Her work has advanced understanding of insulin signaling in AD, glyburide's effects on amyloid pathology, and the role of ATP-sensitive potassium channels in metabolic-neurological interactions. She has published over 50 peer-reviewed articles in journals like Brain , Neuron , and Proceedings of the National Academy of Sciences .

Irwin Chaikenمشاهده پروفایل

استاد

• Protein interactions in health and disease
• HIV-1 Env structure-based antagonism
• Recombinant protein/peptidomimetic/small molecule inhibitor design
• +۵ مورد دیگر

Irwin Chaiken, PhD, is a Professor in the Department of Biochemistry & Molecular Biology at Drexel University College of Medicine. His research focuses on molecular mechanisms of protein interactions, particularly targeting HIV-1 envelope (Env) proteins to develop antiviral therapies. Chaiken holds a PhD from UCLA and an AB from Brown University. Research: Chaiken's lab investigates HIV-1 cell entry mechanisms, designing peptidomimetic inhibitors and evaluating their efficacy for AIDS therapeutics, microbicides, and vaccines. Collaborations include institutions like Columbia University and the Chinese Academy of Sciences. Grants & Awards: Awarded the 2017 CURE Grant and a Campbell Foundation grant for HIV/AIDS research. His work on SARS-CoV-2 inhibitors during the pandemic was supported by Drexel's Rapid Response Fund. Labs & Teams: Leads the Chaiken Research Group, collaborating with interdisciplinary teams to advance virology, protein engineering, and drug development. Past students and postdocs include Andrew Holmes (2016) and Karyn McFadden (2011).

Amy Bergerمشاهده پروفایل

استادیار بالینی

• Physician-Scientist Training
• Clinical Reasoning
• Translational Medicine
• +۳ مورد دیگر

Amy Berger, MD, PhD serves as a Volunteer Assistant Clinical Professor at the University of California, San Francisco School of Medicine, functioning as a physician-scientist at the intersection of clinical medicine and translational research. Her educational background includes: MD, PhD in Neuroscience (2012) - University of California, San Francisco BS in Biological Sciences (2002) - Stanford University Residency in Internal Medicine (2016) - UCSF Fellowships in Academic Hospital Medicine and Clinical and Translational Science (2017) - UCSF Berger's research program focuses on physician-scientist training pathways , pathophysiology-based clinical reasoning , and translating emerging technologies to clinical practice . Her work integrates molecular neuroscience with patient care, particularly in neurology and genetics. Current investigations examine neurodegenerative biomarkers, epilepsy genetics, and metagenomic diagnostic applications. Analysis of her publication record (2008-2024) reveals sustained contributions to translational neuroscience with emphasis on neurogenetics and clinical diagnostics . Her collaborative work spans epilepsy pathology, frontotemporal dementia biomarkers, and metagenomic sequencing for infectious diseases, demonstrating consistent engagement with cutting-edge molecular techniques applied to neurological disorders. Berger actively contributes to physician-scientist development through the Molecular Medicine Investigation Unit at UCSF, focusing on integrated clinical research training models. Her work on opioid receptor trafficking mechanisms represents foundational contributions to addiction pharmacology earlier in her career.

Mark Greenwoodمشاهده پروفایل

استاد

• Statistics
• Data Analysis
• Biostatistics
• +۷ مورد دیگر

Dr. Mark Greenwood is a Professor in the Department of Mathematical Sciences at Montana State University, affiliated with the College of Letters & Science. He holds a B.A. in Mathematics/Statistics from Luther College (1996), and both an M.S. and Ph.D. in Statistics from the University of Wyoming (2000, 2004). His research focuses on advanced statistical methodologies including high-dimensional data analysis, longitudinal modeling, functional data analysis, and measurement error correction. Applications span environmental science, healthcare, and education. Notable contributions include developing statistical frameworks for analyzing BMI trajectories in aging populations and creating molecular diagnostic models for Multiple Sclerosis severity. Teaching encompasses advanced statistical methods courses such as Methods of Data Analysis I/II, Linear Models, and Multivariate Statistics. Awards include the 2020 Excellence in Open Education and the Dr. William A. Stannard Award for Graduate Instruction. Key grants include biomarker research funded by Washington University-St Louis and collaborative CTR-IN initiatives. Professional service includes roles as a reviewer for Plos ONE, Journal of Primary Prevention, and advisory work for BYU-Idaho's Statistics program.

Karl A. Greeneمشاهده پروفایل

استادیار

• Neurosurgery
• Neurology
• Neurochemistry
• +۵ مورد دیگر

Karl A. Greene, MD, PhD, is an Assistant Professor in the Department of Neurosurgery at the Medical College of Wisconsin (MCW) Green Bay. He is a board-certified neurosurgeon specializing in neurosurgical care for brain tumors, vascular malformations, craniovertebral abnormalities, spinal disorders, and spinal reconstruction. Dr. Greene holds dual degrees in MD and PhD from Stanford University (1981–1989), followed by a neurosurgery residency at the Barrow Neurological Institute. His career includes roles as Director of Neurosciences at a tertiary care center in Pennsylvania and 20 years at the NeuroSpine Center of Wisconsin. Education : MD and PhD in Neurosciences, Stanford University Internship in General Surgery, Good Samaritan Regional Medical Center Residency in Neurological Surgery, Barrow Neurological Institute Research Interests : Dr. Greene’s work focuses on neurosurgical treatment strategies for complex spinal and cranial disorders, including traumatic injuries, vascular anomalies, and functional neurosurgery. His research integrates neurochemistry and psychopharmacology with clinical practice, emphasizing translational approaches to neurological recovery. He has authored over 70 publications and pioneered techniques in microsurgery, spinal stabilization, and deep brain stimulation. Publications : His articles highlight advancements in spinal trauma management, vasospasm treatment, and functional neurosurgical procedures. Recent work addresses multidisciplinary approaches to gunshot wounds and intraoperative monitoring for tremor disorders. Awards : Fellow of the American Association of Neurological Surgeons (FAANS) Fellow of the American College of Surgeons (FACS) Labs/Teams : He contributed to the NeuroSpine Center of Wisconsin, a multispecialty group, and collaborated on cutting-edge surgical techniques at leading institutions.

• Neurocritical Care
• Neurotrauma
• Artificial Intelligence in Healthcare
• +۳ مورد دیگر

Joshua E. Medow is a tenured Professor of Neurological Surgery, Neurology, and Biomedical Engineering at the Medical College of Wisconsin. He serves as the Division Chief of Inpatient Neurology, Director of Neurocritical Care, Neurotrauma, and Chief of Inpatient Operations in the Department of Neurology. Previously, he held leadership roles at the University of Wisconsin Hospital in Madison, including Director of Neurocritical Care and Vice Chair of Quality. His work has significantly reduced mortality rates and healthcare costs in neurocritical care settings. Dr. Medow holds an MD from the University of Illinois College of Medicine, an MSc and PhD in Clinical Investigation/Informatics from the University of Wisconsin, and completed neurosurgery residency and fellowships in critical care and endovascular neurosurgery at the University of Wisconsin. His research focuses on AI-driven decision support systems, medical device innovation, and cost-effective healthcare solutions. Key projects include the 'Digital Intern' algorithm for blood management and startups developing smart CSF shunts and safer lumbar drain technologies. His lab integrates engineers, computer scientists, and clinicians to advance personalized medicine and healthcare efficiency. Awards recognize his excellence in patient care, teaching, and research. He is quadruple boarded in neurosurgery, neurocritical care, and clinical informatics. His work emphasizes translational research, with over a decade of contributions to improving clinical outcomes through technology and informatics.

• Knowledge Management
• Strategic Management
• Quality Management
• +۴ مورد دیگر

Pieris Chourides is the current Dean and Associate Professor at the School of Business Administration, European University Cyprus (EUC). He holds a PhD in Knowledge Management from De Montfort University (UK) and has extensive academic and industry experience. His roles include leadership in research and strategic planning, and他曾 served as Head of Research at Cyprus Employers and Industrialist Federation (OEB) and as a visiting lecturer at institutions like De Montfort University and Swiss Management University. Education: PhD in Knowledge Management (De Montfort University, UK, 2005) MSc in Strategic Management (University of Derby, UK, 1999) BEng in Electrical and Electronics Engineering (University of Derby, UK, 1998) Research interests focus on Knowledge Management, Strategic Agility, Quality Management, and their applications in tourism, entrepreneurship, and energy sectors. His work explores topics like blockchain-supported knowledge transfer, CSR's role in firm value, and safety perceptions in energy industries. He has supervised PhD theses on strategic agility and corporate strategy. Awards: European Excellence Award Assessor (EFQM) Emerald Award (MAAOE) Core Advisor Investor In People (IIP) He has managed research projects such as 'Green Entrepreneurship Training' (Erasmus+ Project Manager) and 'Supportive Entrepreneurship in Cultural Industries'. His consulting roles include editorial board membership for the Electronic Journal of Knowledge Management and committee roles in the European Conference for Knowledge Management. Labs/Teams: Active in interdisciplinary research teams focusing on innovation ecosystems and quality management initiatives within the School of Business Administration.

Juan Eugenio Iglesiasمشاهده پروفایل

استاد پژوهشی

• Machine Learning
• Medical Imaging
• Neuroscience
• +۳ مورد دیگر

Juan Eugenio Iglesias is a Research Professor at the Martinos Center for Biomedical Imaging, affiliated with Massachusetts General Hospital (MGH) and Harvard Medical School. He directs the Laboratory for Ex vivo Modeling of Neuroanatomy (LEMoN) and co-directs the Center for Machine Learning. His academic background includes a Telecommunications Engineering degree from ETSI, a double degree in Electrical Engineering from the Stockholm Royal Institute of Technology (KTH), a PhD in Biomedical Engineering from UCLA, and postdoctoral research at the Martinos Center and BCBL in San Sebastián. He holds notable fellowships, including a Marie-Sklodowska Curie Fellowship and a Fulbright Scholarship, and received an ERC Starting Grant to fund his teaching role at University College London before returning to MGH in 2018. Research Interests: Iglesias specializes in applying machine learning to analyze brain MRI images, particularly focusing on ex vivo neuroanatomy modeling, clinical and low-field MRI interpretation, and understanding consciousness through brainstem connectivity. His work emphasizes scalable, resolution-agnostic approaches for neuroimaging tasks, including segmentation, super-resolution, and registration. He also investigates brain tumor segmentation challenges (e.g., BraTS-METS) and integrates dissection photography with AI for neuropathology analysis. Scientific Awards: European Research Council Starting Grant Marie-Sklodowska Curie Fellowship Fulbright Scholarship Advising & Grants: His ERC grant supported his prior position at UCL. Current projects include pediatric brain tumor segmentation, portable MRI applications in stroke and traumatic brain injury, and developing tools like USLR for longitudinal brain MRI analysis. Collaborations with companies like Endesa reflect his engineering background. Labs & Teams: Leads LEMoN Lab and co-directs the Center for Machine Learning. Engages in interdisciplinary teams for projects such as H-SynEx (hypothalamus segmentation) and PEPSI (MRI contrast-agnostic representations).

Raquel Espin Palazonمشاهده پروفایل

استادیار

• Hematology
• Regenerative Medicine
• Developmental Biology
• +۳ مورد دیگر

Raquel Espin Palazon is an Assistant Professor at Iowa State University (ISU), focusing on regenerative medicine and blood disorder research. Her work employs zebrafish models to study blood formation mechanisms during embryonic development, with translational applications to human health through in vitro studies and bioinformatics. She emphasizes interdisciplinary collaboration and contributes to ISU's commitment to excellence in Biology education. Education: B.S. Biology, University of Murcia, Spain M.S. Molecular Biology and Biotechnology, University of Murcia, Spain Ph.D. Cell and Molecular Biology, University of Murcia, Spain Research Interests: Her lab investigates hematopoietic stem cell emergence, inflammatory signaling, and vascular biology. Key topics include the role of proinflammatory cytokines in blood formation, TNF-alpha pathways in immunity, and zebrafish as a model for understanding blood disorders like myelodysplasia and leukemia. Techniques include single-cell analysis, bioinformatics, and in vivo imaging. Publications: Recent work highlights contributions to understanding lineage conversion, Wnt signaling in stem cell development, and Gata2b’s role in hemogenic endothelium. Her studies bridge basic science and clinical applications, emphasizing translational outcomes. Grants and Training: While specific grants are not listed, her research is supported by institutional and collaborative funding. She mentors students in experimental and computational biology, fostering the next generation of scientists. Labs/Teams: Her lab (Espin Lab) integrates molecular, cellular, and computational approaches. Collaborations with peers at ISU and beyond drive innovation in regenerative medicine and developmental biology.

• Neurodegenerative Diseases
• Mitochondrial Dysfunction
• Retinal Degeneration
• +۴ مورد دیگر

Dr. Marzena Kurzawa-Akanbi is a Research Fellow at Newcastle University's Faculty of Medical Sciences, with appointments in the Institute of Genetic Medicine and Institute of Neuroscience. Her research focuses on neurodegenerative diseases, mitochondrial dysfunction, and retinal degeneration. She leads interdisciplinary projects investigating mechanisms underlying Parkinson’s disease, Alzheimer’s disease, and age-related macular degeneration (AMD), with particular emphasis on stem cell modeling and biomarker discovery. Institution: Newcastle University Departments: Institute of Genetic Medicine & Institute of Neuroscience Key Collaborators: Professors David Steel, Majlinda Lako, Patrick Chinnery Her work combines molecular genetics, cell biology, and clinical pathology to uncover disease mechanisms. Recent studies include: Developing iPSC models for retinal dystrophies (e.g., DRAM2-dependent CORD21) Investigating lysosomal dysfunction in AMD using retinal pigment epithelium extracellular vesicles Characterizing mitochondrial DNA changes in Parkinson's patients' cerebrospinal fluid She has pioneered methods to assess mitochondrial biomarkers in neurodegenerative disorders and contributed to understanding glucocerebrosidase mutations in Lewy body diseases. Her research bridges basic science and translational medicine, aiming to identify novel therapeutic targets.

• Neuroimmunology
• Multiple Sclerosis
• Autoimmune Encephalitis
• +۳ مورد دیگر

Max Kaufmann is a Professor at the University of Hamburg, affiliated with the Department of Neuroimmunology and Multiple Sclerosis within the Faculty of Medicine. His research focuses on neuroimmunological mechanisms underlying autoimmune diseases, particularly multiple sclerosis (MS) and autoimmune encephalitis. Key areas include understanding T cell biology in neurodegenerative pathways, genetic predisposition, and therapeutic targets for CNS pathologies. His work spans clinical and translational research, with contributions to stem cell transplantation in MS, CSF biomarkers for autoimmune encephalitis, and molecular mechanisms of neuronal vulnerability. He leads studies integrating single-cell analysis and genetic approaches to uncover disease mechanisms. Publications highlight discoveries in T cell colonization in infants, early neurodegenerative pathways in MS, and genetic loci associated with anti-NMDAR encephalitis. His findings bridge basic immunology with clinical applications, aiming to improve diagnostics and therapies for neuroimmune disorders.

• Multiple Sclerosis
• MRI Imaging
• Neuroimmunology
• +۷ مورد دیگر

Dr. Christopher Corey Thomson Hemond is an Assistant Professor at UMass Chan Medical School within the Department of Neurology, with additional appointments in the T.H. Chan School of Medicine, NeuroNexus Institute, and Morningside Graduate School of Biomedical Sciences across MD/PhD, Neuroscience, and Translational Science programs. BS in Brain & Cognitive Science from Massachusetts Institute of Technology MD from Stanford University Dr. Hemond is a board-certified neurologist with clinical subspecialty training in neuroimmunology and multiple sclerosis. His research focuses on developing and validating MRI-based biomarkers to improve early identification and pathophysiological understanding of neurodegenerative processes in MS. His lab utilizes high-resolution MRI sequences, including structural, susceptibility-sensitive (iron), and diffusion imaging to characterize microstructural MS lesion features. Recent work incorporates deep learning models to accelerate identification and segmentation of novel CNS structures relevant to neuroinflammatory disease. Analysis of Dr. Hemond's publications reveals a strong focus on paramagnetic rim lesions as specific biomarkers for MS diagnosis and progression. His work spans neuroimaging, fluid biomarker development, Epstein-Barr virus research, and psychoneuroimmunological aspects of MS, particularly mindfulness-based interventions for symptom management. His publications consistently address the interface between imaging findings and underlying biological mechanisms in MS. 2022-2023: Riccio Foundation Award for CSF antibody profiling in MS 2020-2022: UMass PACE award for EBV-specific T cell responses in MS 2020-2024: Consortium of MS Centers award for mindfulness-based stress reduction research 2020-2022: NIH KL2 award for neurodegeneration prediction in MS 2018-2024: MS Foundation award for mindfulness interventions 2018-2020: National MS Society award for memory B-cell research Current NIH K23 grant (2022-2027) on paramagnetic rim lesions Dr. Hemond leads the Hemond Lab with a team including Mugdha Deshpande (clinical research coordinator), several medical students, and graduate researchers. His lab collaborates extensively with Dr. Carolina Ionete's MS biorepository and the NIH Translational Neuroradiology Section. Current projects include deep learning for brain structure segmentation, neural immune interface imaging, and mindfulness intervention studies for MS symptom management.

• Neurology
• Biochemistry
• Molecular Biology
• +۴ مورد دیگر

Melissa Sue Rotunno is an Assistant Professor at UMass Chan Medical School , affiliated with the T.H. Chan School of Medicine and the Morningside Graduate School of Biomedical Sciences . Her primary department is Neurology , with additional roles in Biochemistry and Molecular Biotechnology, Neuroscience, and the NeuroNexus Institute. Education: BS in Microbiology, University of Rhode Island PhD in Biomedical Sciences, University of Massachusetts Medical School Research Interests focus on neurodegenerative diseases, including ALS, Parkinson's, and Alzheimer's, with emphasis on protein misfolding, biomarkers, and molecular pathology. Her work integrates proteomics, iPSC models, and post-translational modifications to uncover disease mechanisms. Publications span proteomic studies of ALS and Parkinson's, SOD1 misfolding, Tau protein modifications in Alzheimer's, and FUS toxicity in ALS. Keywords include biochemistry , neuroscience , and molecular biology . Networks include collaborations with researchers like Daryl Bosco, Scott Shaffer, and Miguel Sena-Esteves. Her work relates to concepts such as Chromogranins , Epitopes , and Neurodegenerative Diseases .

• Sustainable Construction
• Construction Management
• Sustainability
• +۳ مورد دیگر

Yasemin Nielsen is an Associate Professor at the School of Energy, Geoscience, Infrastructure and Society, Heriot-Watt University. Her research focuses on sustainable construction practices, energy efficiency, and stakeholder management in built environment projects. She holds an ORCID identifier: 0000-0001-9800-3581 . Her work aligns with UN Sustainable Development Goals, particularly addressing climate action (SDG 13) and responsible consumption (SDG 12). Research interests include innovative materials like fly ash in construction, optimizing energy consumption in residential buildings, and analyzing stakeholder dynamics in sustainable projects. Recent publications (2023-2025) explore: Material science advancements for sustainable construction Energy forecasting in UAE housing sectors Stakeholder management frameworks Project success metrics for green building initiatives No specific grants or awards are listed in the provided profile. She collaborates internationally, evidenced by UAE-based case studies and cross-border research partnerships.

Fernanda de Feliceمشاهده پروفایل

دانشیار

• Neurosciences
• Alzheimer’s Disease
• Type 2 Diabetes/Obesity
• +۵ مورد دیگر

Fernanda de Felice is an Associate Professor in the Department of Biomedical and Molecular Sciences at Queen's University, cross-appointed to Psychiatry and affiliated with the Centre for Neuroscience Studies and Translational Institute of Medicine. She holds an adjunct role at Queen's and maintains a primary appointment at the Federal University of Rio de Janeiro. Her research focuses on Alzheimer’s disease mechanisms linked to diabetes and inflammation, particularly insulin resistance in the brain and exercise-related neuroprotection via hormones like irisin. Education: PhD in Biological Chemistry (2002) from Federal University of Rio de Janeiro, postdoctoral training at Northwestern University under Prof. William Klein. Cross appointments include Centre for Neuroscience Studies and TIME. Research interests center on the interplay between metabolic disorders and neurodegeneration. Key contributions include identifying irisin's role in synaptic protection and developing non-human primate models of Alzheimer’s. Active in Latin American dementia initiatives through LAC-CD consortium. Affiliations: D’Or Research Institute (Investigator), Queen’s University (since 2021), and Federal University of Rio de Janeiro (since 2009). Her work spans cellular, molecular, and translational research with over 50 peer-reviewed publications.